1887
Preview this article:
Zoom in
Zoomout

In the beginning: genome recognition, RNA encapsidation and the initiation of complex retrovirus assembly, Page 1 of 1

| /docserver/preview/fulltext/jgv/81/8/0811889a-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-81-8-1889
2000-08-01
2019-10-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/81/8/0811889a.html?itemId=/content/journal/jgv/10.1099/0022-1317-81-8-1889&mimeType=html&fmt=ahah

References

  1. Arthur, L. O., Bess, J. W., Chertova, E. N., Rossio, J. L., Esser, M. T., Benveniste, R. E., Henderson, L. E. & Lifson, J. D. ( 1998; ). Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine. AIDS Research and Human Retroviruses 14, 311-319.[CrossRef]
    [Google Scholar]
  2. Berg, J. M. & Shi, Y. ( 1996; ). The galvanization of biology: a growing appreciation for the roles of zinc. Science 271, 1081-1085.[CrossRef]
    [Google Scholar]
  3. Berkowitz, R. D., Ohagen, A., Hoglund, S. & Goff, S. P. ( 1995; ). Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric gag polyproteins during RNA packaging in vivo. Journal of Virology 69, 6445-6456.
    [Google Scholar]
  4. Berkowitz, R., Fisher, J. & Goff, S. P. ( 1996; ). RNA packaging. Current Topics in Microbiology and Immunology 214, 177-218.
    [Google Scholar]
  5. Burniston, M. T., Cimarelli, A., Colgan, J., Curtis, S. P. & Luban, J. ( 1999; ). Human immunodeficiency virus type 1 gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid–dimer interface and the basic region of matrix protein. Journal of Virology 73, 8527-8540.
    [Google Scholar]
  6. Cimarelli, A., Sandin, S., Hoglund, S. & Luban, J. ( 2000; ). Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA. Journal of Virology 74, 3046-3057.[CrossRef]
    [Google Scholar]
  7. De Guzman, R. N., Wu, Z. R., Stalling, C. C., Pappalardo, L., Borer, P. N. & Summers, M. F. ( 1998; ). Structure of the HIV-1 nucleocapsid protein bound to the SL3 psi–RNA recognition element. Science 279, 384-388.[CrossRef]
    [Google Scholar]
  8. Dupont, S., Sharova, N., DeHoratius, C., Virbasius, C. M., Zhu, X., Bukrinskaya, A. G., Stevenson, M. & Green, M. R. ( 1999; ). A novel nuclear export activity in HIV-1 matrix protein required for viral replication. Nature 402, 681-685.[CrossRef]
    [Google Scholar]
  9. Enssle, J., Fischer, N., Moebes, A., Mauer, B., Smola, U. & Rethwilm, A. ( 1997; ). Carboxy-terminal cleavage of the human foamy virus Gag precursor molecule is an essential step in the viral life cycle. Journal of Virology 71, 7312-7317.
    [Google Scholar]
  10. Erlwein, O., Cain, D., Fischer, N., Rethwilm, A. & McClure, M. O. ( 1997; ). Identification of sites that act together to direct dimerization of human foamy virus RNA in vitro. Virology 229, 251-258.[CrossRef]
    [Google Scholar]
  11. Erlwein, O., Bieniasz, P. D. & McClure, M. O. ( 1998; ). Sequences in pol are required for transfer of human foamy virus-based vectors. Journal of Virology 72, 5510-5516.
    [Google Scholar]
  12. Freed, E. O. ( 1998; ). HIV-1 Gag proteins: diverse functions in the virus life cycle. Virology 251, 1-15.[CrossRef]
    [Google Scholar]
  13. Gorelick, R. J., Chabot, D. J., Rein, A., Henderson, L. E. & Arthur, L. O. ( 1993; ). The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. Journal of Virology 67, 4027-4036.
    [Google Scholar]
  14. Harrison, G. P., Miele, G., Hunter, E. & Lever, A. M. L. ( 1998; ). Functional analysis of the core human immunodeficiency virus type 1 packaging signal in a permissive cell line. Journal of Virology 72, 5886-5896.
    [Google Scholar]
  15. Heinkelein, M., Schmidt, M., Fischer, N., Moebes, A., Lindemann, D., Enssle, J. & Rethwilm, A. ( 1998; ). Characterization of a cis-acting sequence in the Pol region required to transfer human foamy virus vectors. Journal of Virology 72, 6307-6314.
    [Google Scholar]
  16. Helga-Maria, C., Hammarskjold, M.-L. & Rekosh, D. ( 1999; ). An intact TAR element and cytoplasmic localization are necessary for efficient packaging of human immunodeficiency virus type 1 genomic RNA. Journal of Virology 73, 4127-4135.
    [Google Scholar]
  17. Katoh, I., Kyushiki, H., Sakamoto, Y., Ikawa, Y. & Yoshinaka, Y. ( 1991; ). Bovine leukemia virus matrix-associated protein MA(p15): further processing and formation of a specific complex with the dimer of the 5’ terminal genomic RNA fragment. Journal of Virology 65, 6845-6855.
    [Google Scholar]
  18. Katoh, I., Yasunaga, T. & Yoshinaka, Y. ( 1993; ). Bovine leukemia virus RNA sequences involved in dimerization and specific gag protein binding: close relation to the packaging sites of avian, murine, and human retroviruses. Journal of Virology 67, 1830-1839.
    [Google Scholar]
  19. Katz, R. A., Terry, R. W. & Skalka, A. M. ( 1986; ). A conserved cis-acting sequence in the 5’ leader of avian sarcoma virus RNA is required for packaging. Journal of Virology 59, 163-167.
    [Google Scholar]
  20. Kaye, J. F. & Lever, A. M. L. ( 1998; ). Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation. Journal of Virology 72, 5877-5885.
    [Google Scholar]
  21. Kaye, J. F. & Lever, A. M. L. ( 1999; ). Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation. Journal of Virology 73, 3023-3031.
    [Google Scholar]
  22. Kaye, J. F., Richardson, J. H. & Lever, A. M. L. ( 1995; ). cis-Acting sequences involved in human immunodeficiency virus type 1 RNA packaging. Journal of Virology 69, 6588-6592.
    [Google Scholar]
  23. Klug, A. ( 1999; ). Zinc finger peptides for the regulation of gene expression. Journal of Molecular Biology 293, 215-218.[CrossRef]
    [Google Scholar]
  24. Linial, M. L. ( 1999; ). Foamy viruses are unconventional retroviruses. Journal of Virology 73, 1747-1755.
    [Google Scholar]
  25. Liu, B., Dai, R., Tian, C. J., Dawson, L., Gorelick, R. & Yu, X. F. ( 1999; ). Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. Journal of Virology 73, 2901-2908.
    [Google Scholar]
  26. Lochrie, M. A., Waugh, S., Pratt, D. G., Clever, J., Parslow, T. G. & Polisky, B. ( 1997; ). In vitro selection of RNAs that bind to the human immunodeficiency virus type 1 gag polyprotein. Nucleic Acids Research 25, 2902-2910.[CrossRef]
    [Google Scholar]
  27. Luban, J. & Goff, S. P. ( 1994; ). Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA. Journal of Virology 68, 3784-3793.
    [Google Scholar]
  28. McBride, M. S. & Panganiban, A. T. ( 1996; ). The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures. Journal of Virology 70, 2963-2973.
    [Google Scholar]
  29. McBride, M. S. & Panganiban, A. T. ( 1997; ). Position dependence of functional hairpins important for human immunodeficiency virus type 1 RNA encapsidation in vivo. Journal of Virology 71, 2050-2058.
    [Google Scholar]
  30. McBride, M. S., Schwartz, M. D. & Panganiban, A. T. ( 1997; ). Efficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis-elements required for encapsidation. Journal of Virology 71, 4544-4554.
    [Google Scholar]
  31. McCann, E. M. & Lever, A. M. L. ( 1997; ). Location of cis-acting signals important for RNA encapsidation in the leader sequence of human immunodeficiency virus type 2. Journal of Virology 71, 4133-4137.
    [Google Scholar]
  32. McDonnell, N. B., De Guzman, R. N., Rice, W. G., Turpin, J. A. & Summers, M. F. ( 1997; ). Zinc ejection as a new rationale for the use of cystamine and related disulfide-containing antiviral agents in the treatment of AIDS. Journal of Medicinal Chemistry 49, 1969-1976.
    [Google Scholar]
  33. Mansky, L. M., Krueger, A. E. & Temin, H. M. ( 1995; ). The bovine leukemia virus encapsidation signal is discontinuous and extends into the 5’ end of the gag gene. Journal of Virology 69, 3282-3289.
    [Google Scholar]
  34. Mansky, L. M. & Wisniewski, R. M. ( 1998; ). The bovine leukemia virus encapsidation signal is composed of RNA secondary structures. Journal of Virology 72, 3196-3204.
    [Google Scholar]
  35. Morikawa, Y., Goto, T. & Sano, K. ( 1999; ). In vitro assembly of human immunodeficiency virus type 1 Gag protein. Journal of Biological Chemistry 274, 27997-28002.[CrossRef]
    [Google Scholar]
  36. Morikawa, Y., Hockley, D. J., Nermut, M. V. & Jones, I. M. ( 2000; ). Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly. Journal of Virology 74, 16-23.[CrossRef]
    [Google Scholar]
  37. Mougel, M., Zhang, Y. & Barklis, E. ( 1996; ). cis-Active structural motifs involved in specific encapsidation of moloney murine leukemia virus RNA. Journal of Virology 70, 5043-5050.
    [Google Scholar]
  38. Ott, D. E., Hewes, S. M., Alvord, W. G., Henderson, L. E. & Arthur, L. O. ( 1998; ). Inhibition of Friend virus replication by a compound that reacts with the nucleocapsid zinc finger: anti-retroviral effect demonstrated in vivo. Virology 243, 283-292.[CrossRef]
    [Google Scholar]
  39. Parent, L. J., Cairns, T. M., Albert, J. A., Wilson, C. B., Wills, J. W. & Craven, R. C. ( 2000; ). RNA dimerization defect in a Rous sarcoma virus matrix mutant. Journal of Virology 74, 164-172.[CrossRef]
    [Google Scholar]
  40. Pfrepper, K. I., Lochelt, M., Rackwitz, H. R., Schnolzer, M., Heid, H. & Flugel, R. M. ( 1999; ). Molecular characterization of proteolytic processing of the Gag proteins of human spumavirus. Journal of Virology 73, 7907-7911.
    [Google Scholar]
  41. Poon, D. T. K., Wu, J. & Aldovini, A. ( 1996; ). Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity. Journal of Virology 70, 6607-6616.
    [Google Scholar]
  42. Poon, D. T. K., Li, G. & Aldovini, A. ( 1998; ). Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging. Journal of Virology 72, 1983-1993.
    [Google Scholar]
  43. Reil, H., Bukovsky, A. A., Gelderblom, H. R. & Gottlinger, H. G. ( 1998; ). Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO Journal 17, 2699-2708.[CrossRef]
    [Google Scholar]
  44. Rein, A. (1994). Retroviral RNA packaging: a review. Archives of Virology, Supplementum 9, 513–522.
  45. Rein, A., Henderson, L. E. & Levin, J. G. ( 1998; ). Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: significance for viral replication. Trends in Biochemical Sciences 23, 297-301.[CrossRef]
    [Google Scholar]
  46. Rice, W. G., Turpin, J. A., Huang, M., Clanton, D., Buckheit, R. W. J., Covell, D. G., Wallqvist, A., McDonnell, N. B., DeGuzman, R. N., Summers, M. F., Zalkow, L., Bader, J. P., Haugwitz, R. D. & Sausville, E. A. ( 1997; ). Azodicarbonamide inhibits HIV-1 replication by targeting the nucleocapsid protein. Nature Medicine 3, 341-345.[CrossRef]
    [Google Scholar]
  47. Schmalzbauer, E., Strack, B., Dannull, J., Guehmann, S. & Moelling, K. ( 1996; ). Mutations of basic amino acids of NCp7 of human immunodeficiency virus type 1 affect RNA binding in vitro. Journal of Virology 70, 771-777.
    [Google Scholar]
  48. Schwartz, M. D., Fiore, D. & Panganiban, A. T. ( 1997; ). Distinct functions and requirements for the cys-his boxes of the human immunodeficiency virus type 1 nucleocapsid protein during RNA encapsidation and replication. Journal of Virology 71, 9295-9305.
    [Google Scholar]
  49. Swanstrom, R. & Wills, J. W. ( 1997; ). Synthesis, assembly, and processing of viral proteins. In Retroviruses, pp. 263-334. Edited by J. M. Coffin, S. H. Hughes & H. E. Varmus. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
  50. Tassignon, J., Ismaili, J., Le Moine, A., Van Laethem, F., Leo, O., Vandevelde, M. & Goldman, M. ( 1999; ). Azodicarbonamide inhibits T-cell responses in vitro and in vivo. Nature Medicine 5, 947-950.[CrossRef]
    [Google Scholar]
  51. Wilk, T., Gowen, B. & Fuller, S. D. ( 1999; ). Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. Journal of Virology 73, 1931-1940.
    [Google Scholar]
  52. Wu, M., Chari, S., Yanchis, T. & Mergia, A. ( 1998; ). cis-Acting sequences required for simian foamy virus type 1 vectors. Journal of Virology 72, 3451-3454.
    [Google Scholar]
  53. Yu, S. F., Edelmann, K., Strong, R. K., Moebes, A., Rethwilm, A. & Linial, M. L. ( 1996; ). The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domains. Journal of Virology 70, 8255-8262.
    [Google Scholar]
  54. Yu, S. F., Sullivan, M. D. & Linial, M. L. ( 1999; ). Evidence that the human foamy virus genome is DNA. Journal of Virology 73, 1565-1572.
    [Google Scholar]
  55. Zeffman, A., Hassard, S., Varani, G. & Lever, A. ( 2000; ). The major HIV-1 packaging signal is an extended bulged stem loop whose structure is altered on interaction with the Gag polyprotein. Journal of Molecular Biology 297, 877-893.[CrossRef]
    [Google Scholar]
  56. Zhang, Y., Qian, H., Love, Z. & Barklis, E. ( 1998; ). Analysis of the assembly function of the human immunodeficiency virus type 1 Gag protein nucleocapsid domain. Journal of Virology 72, 1782-1789.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-81-8-1889
Loading
/content/journal/jgv/10.1099/0022-1317-81-8-1889
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error